Stocks and Investing Stocks and Investing
Wed, July 1, 2020
Tue, June 30, 2020

Serge Belanger Maintained (VRCA) at Strong Buy with Decreased Target to $17 on, Jun 30th, 2020


Published on 2024-10-27 08:52:59 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Decreased Target from $20 to $17 on, Jun 30th, 2020.

Serge has made no other calls on VRCA in the last 4 months.



There is 1 other peer that has a rating on VRCA. Out of the 1 peers that are also analyzing VRCA, 0 agree with Serge's Rating of Hold.



This is the rating of the analyst that currently disagrees with Serge


  • Tim Chiang of "Northland Capital Markets" Initiated at Buy and Held Target at $21 on, Wednesday, June 24th, 2020
Contributing Sources